首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO,a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia
Authors:Ronald M. Goldenberg MD  Vanita R. Aroda MD  Liana K. Billings MD  A. Sia Louise Christiansen MSc  Anders Meller Donatsky MD  Ehsan Parvaresh Rizi MD  Gracjan Podgorski MD  Katarina Raslova MD  David C. Klonoff MD  Richard M. Bergenstal MD
Affiliation:1. LMC Diabetes and Endocrinology, Concord, Ontario, Canada;2. Diabetes Clinical Research, Division of Endocrinology, Diabetes & Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA;3. Department of Medicine, NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine, Skokie, Illinois, USA;4. Biostatistics, Insulin & Devices, Novo Nordisk, Søborg, Denmark;5. Medical & Science, New Generation Insulins, Novo Nordisk, Søborg, Denmark;6. Global Medical Affairs, Novo Nordisk, Søborg, Denmark;7. Internal Medicine, Greenacres Hospital, Port Elizabeth, South Africa;8. Metabolic Center Ltd, Bratislava, Slovakia;9. Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA;10. International Diabetes Center and HealthPartners Institute, Minneapolis, MN, USA
Abstract:
Keywords:basal insulins  insulin analogues  insulin treatment  long-acting basal insulin  professional CGM  type 2
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号